CHC Healthcare Group (TPE:4164)

Market Cap	5.92B -37.7%
Revenue (ttm)	4.40B +22.2%
Net Income	186.28M +10.6%
EPS	1.00 +1.6%
Shares Out	195.31M
PE Ratio	30.39
Forward PE	16.88
Dividend	1.10 (3.63%)
Ex-Dividend Date	Jun 26, 2025

Volume	778,716
Average Volume	1,160,656
Open	30.60
Previous Close	30.70
Day's Range	30.10 - 30.70
52-Week Range	29.90 - 53.00
Beta	0.20
RSI	40.43
Earnings Date	May 7, 2026

About CHC Healthcare Group

CHC Healthcare Group, together with its subsidiaries, trades in medical equipment, pharmaceutical products, and health food in Taiwan, China, and internationally. The company is also involved in the leasing, installing, servicing, and repairing of medical instruments for use in various specialties, such as radiation oncology, medical imaging, neurology, surgery, ophthalmology, robot rehabilitation, dentistry, and smart health care. In addition, it engages in the irradiation business; sale of daily necessities, beauty products, and health supple...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 2009
• Country: Taiwan
• Stock Exchange: Taiwan Stock Exchange
• Ticker Symbol: 4164

Financial Performance

In 2025, CHC Healthcare Group's revenue was 4.40 billion, an increase of 22.15% compared to the previous year's 3.60 billion. Earnings were 186.28 million, an increase of 10.63%.